Autolus Therapeutics (AUTL)
1.54
-0.12 (7.23%)
Upcoming Events
Latest Headlines
Autolus Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2026 7:00 AM - StreetInsider
Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
May 21, 2026 5:10 PM - Globe NewsWire
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
May 19, 2026 6:30 AM - PR NewsWire
Byondis forms scientific advisory board with oncology experts
May 18, 2026 7:00 AM - StreetInsider
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
May 18, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A Autolus Therapeutics Filed by: MAK Capital Fund LP
May 15, 2026 3:05 PM - SEC Filing
Form SCHEDULE 13G/A Autolus Therapeutics Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:06 AM - SEC Filing
Autolus Therapeutics plc (AUTL) PT Lowered to $5.40 at Goldman Sachs
May 15, 2026 6:29 AM - StreetInsider
Form 10-Q Autolus Therapeutics For: Mar 31
May 14, 2026 4:32 PM - SEC Filing
Form 8-K Autolus Therapeutics For: May 14
May 14, 2026 7:54 AM - SEC Filing
Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
May 14, 2026 7:08 AM - StreetInsider
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
May 14, 2026 7:00 AM - Globe NewsWire
Form EFFECT Autolus Therapeutics
May 6, 2026 6:08 AM - SEC Filing
Form EFFECT Autolus Therapeutics
May 6, 2026 6:08 AM - SEC Filing
Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026
May 5, 2026 7:00 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Autolus Therapeutics plc (AUTL)
April 30, 2026 6:55 AM - StreetInsider
Form 8-K Autolus Therapeutics For: Apr 29
April 29, 2026 5:29 PM - SEC Filing
Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost Reduction
April 29, 2026 4:05 PM - StreetInsider
Prilenia names Dr. Elisabeth Leiderman as chief financial officer
April 28, 2026 8:00 AM - StreetInsider
Prilenia Appoints Dr. Elisabeth Leiderman as Chief Financial Officer
April 28, 2026 8:00 AM - BizWire
AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance
April 27, 2026 11:59 AM - Globe NewsWire
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
April 22, 2026 8:30 AM - Globe NewsWire
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2026 4:10 PM - StreetInsider
Form 8-K Autolus Therapeutics For: Apr 14
April 16, 2026 4:08 PM - SEC Filing
Form DEL AM Autolus Therapeutics
April 15, 2026 10:31 AM - SEC Filing
Form DEL AM Autolus Therapeutics
April 15, 2026 6:21 AM - SEC Filing
Asgard Therapeutics names Wolfram Brugger as chief medical officer
April 14, 2026 3:30 AM - StreetInsider
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
April 14, 2026 3:30 AM - Globe NewsWire
Autolus Therapeutics (AUTL) files $150M mixed shelf
April 13, 2026 6:13 AM - StreetInsider
Autolus Therapeutics (AUTL) files for 54.58M share offering by selling stockholders
April 13, 2026 6:11 AM - StreetInsider
Form S-3 Autolus Therapeutics
April 13, 2026 6:02 AM - SEC Filing
Form S-3 Autolus Therapeutics
April 13, 2026 6:02 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Autolus Therapeutics plc (AUTL)
April 9, 2026 6:42 AM - StreetInsider
Form 8-K Autolus Therapeutics For: Apr 08
April 8, 2026 4:17 PM - SEC Filing
Autolus Therapeutics to Participate in Upcoming Investor Conferences
April 7, 2026 9:39 AM - Globe NewsWire
Autolus Therapeutics to Participate in Upcoming Investor Conferences
April 7, 2026 7:00 AM - StreetInsider
Autolus Therapeutics plc (AUTL) PT Lowered to $10 at Mizuho
March 31, 2026 6:34 AM - StreetInsider
William Blair on Autolus Therapeutics plc (AUTL): LT blockbuster oppty despite YTD stock decline
March 27, 2026 4:45 PM - StreetInsider
Form 10-K Autolus Therapeutics For: Dec 31
March 27, 2026 4:40 PM - SEC Filing
Mizuho Reiterates on Autolus Therapeutics plc (AUTL): Ph1 readouts could show path forward
March 27, 2026 12:50 PM - StreetInsider
Autolus Therapeutics (AUTL) Misses Q4 EPS by 9c
March 27, 2026 8:14 AM - StreetInsider
Form 8-K Autolus Therapeutics For: Mar 27
March 27, 2026 8:02 AM - SEC Filing
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
March 27, 2026 7:00 AM - StreetInsider
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Richardson Ryan
March 23, 2026 4:54 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Piccina Cintia
March 18, 2026 8:40 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: BUTITTA CYNTHIA M
March 18, 2026 8:02 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Leiderman Elisabeth
March 18, 2026 8:01 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Will Matthias
March 18, 2026 8:00 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: YOUNG WILLIAM D
March 18, 2026 7:59 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Azelby Robert
March 18, 2026 7:58 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Rao Madduri Ravin
March 18, 2026 7:57 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: BONNEY MICHAEL W
March 18, 2026 7:56 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: McIlvenny Patrick Paul
March 18, 2026 7:55 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Dolski Robert
March 18, 2026 7:54 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Bain Linda
March 18, 2026 7:53 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Iannone Robert
March 18, 2026 7:52 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Berriman John E
March 18, 2026 7:52 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Itin Christian
March 18, 2026 7:51 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Pule Martin Anton
March 18, 2026 7:50 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Vann Christopher Andrew
March 18, 2026 7:49 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Williams Christopher Michael James
March 18, 2026 7:48 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Swan Alexander
March 18, 2026 7:47 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Driggs Alex
March 18, 2026 7:46 PM - SEC Filing
Form 3 Autolus Therapeutics For: Mar 18 Filed by: Neville Miranda Suzette
March 18, 2026 7:45 PM - SEC Filing
Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026
March 16, 2026 4:10 PM - StreetInsider
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
March 10, 2026 5:31 PM - PR NewsWire
Full Article List
